Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
Status:
Not yet recruiting
Trial end date:
2024-02-15
Target enrollment:
Participant gender:
Summary
This is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess
Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell
carcinoma (sBCC) on the neck, trunk, or extremities (excluding, axilla, anogenital, and
face/scalp).